Baxter International (NYSE:BAX) will report earnings before markets open on Thursday, July 18th. Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
Here is your Cheat Sheet to Baxter International Earnings:
Earnings Expectations: Analysts expect earnings of $1.13 per share on revenues of $3.70 billion. Currently, the company’s P/E ratio stands at 17.54.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.19 to a profit $1.18. For the current year, the average estimate is a profit of $4.65, which is worse than the estimate ninety days ago.
Here’s how Baxter International has been performing on an annual basis:
|Revenue ($) in millions||12,348||12,562||12,843||13,893||14,190|
|Diluted EPS ($)||3.16||3.59||2.39||3.88||4.18|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||3,572.00||3,477.00||3,753.00||3,448.00|
|Diluted EPS ($)||1.19||1.06||0.89||1.00|
Baxter International has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)